PMCID: PMC3784205
It targets two hormone receptors, GLP-1 and GIP, to help curb appetite, slow digestion, and regulate blood sugar
"Dose adjustments are probably not required for simultaneous use of GLP1RAs with oral medications
Their complementary mechanisms one acting primarily through growth factor upregulation and GI-cytoprotection, the other through actin polymerization and systemic cell migration make them uniquely interesting both individually and as a combined research subject
However, this route involves accepting regulatory ambiguity and personal responsibility for safety monitoring
In older adults, acquired lipodystrophy predominates and is frequently associated with autoimmune diseases (e.g., SLE, dermatomyositis, panniculitis) [204]